🚨 BIG NEWS 🚨
Opticyte is now LIVE on StartEngine!  With investment opportunities starting at $300 and bonuses at higher tiers of investing, you can now be part of our new crowdfunding campaign and support our mission to bring more effective, equitable healthcare to all.
Your single investment helps address two critical and tragic crises facing healthcare today:
➡ Sepsis: The # 1 Cause of Death in US Hospitals:
Sepsis claims nearly 270,000 U.S. lives annually, making it the # 1 cause of hospital deaths. Yet, existing methods often fail to detect signs of this deadly condition, making it difficult to intervene early enough to prevent organ failure, and too often, death.
➡ Pulse Oximeters are Failing People of Color:
Traditional pulse oximeters are used on every hospital patient and make errors in patients with darker skin tones that result in more organ failure and death than in patients with lighter skin.
The Opticyte VitalO₂ provides the industry’s first solution to address both of these critical issues, and for the first time, anyone can invest and help bring this transformative technology to patients.
🤝 Please help by making an investment through StartEngine today: https://www.startengine.com/offering/opticyte
🤝 Please share this post with your community and encourage your friends and family to help us make our vision a reality.
We’re making great progress, and with your support, we can bring VitalO₂ to patients in a matter of months. Together let’s improve patient care for everyone.
Thank you!